Active prescription of low-dose aspirin during or prior to hospitalization and mortality in COVID-19: A systematic review and meta-analysis of adjusted effect estimates

BACKGROUND: This study aimed to investigate whether the active prescription of low-dose aspirin during or prior to hospitalization affects mortality in patients with coronavirus disease 2019 (COVID-19). Aspirin is often prescribed for secondary prevention in patients with cardiovascular disease and...

Descripción completa

Detalles Bibliográficos
Autores principales: Martha, Januar Wibawa, Pranata, Raymond, Lim, Michael Anthonius, Wibowo, Arief, Akbar, Mohammad Rizki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123385/
https://www.ncbi.nlm.nih.gov/pubmed/34000418
http://dx.doi.org/10.1016/j.ijid.2021.05.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123385/
https://www.ncbi.nlm.nih.gov/pubmed/34000418
http://dx.doi.org/10.1016/j.ijid.2021.05.016

Ejemplares similares